More information: Shi-Jian Song et al, Advances in Subcellular Accumulation Design for Recombinant Protein Production in Tobacco, BioDesign Research (2024). DOI: 10.34133/bdr.0047 ...

The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins ...

App Note: Recombinant protein expression using a baculovirus-insect cell system Review: Cell-free protein synthesis: advances on production process for biopharmaceuticals and immunobiological products ...

The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins ...

Pichia pastoris has emerged as a central microbial host for recombinant protein production, offering a unique balance of rapid growth, capacity for post‐translational modifications, and ease of ...

Conversely, the costs for recombinant protein production are much more predictable. Cell culture and fermentation reagents are readily available, and their prices are much more stable than those ...

For recombinant protein vaccine developers, this includes access to effective GMP-grade adjuvants, which have been known to cause bottlenecks in production.

Future Fields is building its first production facility next to its corporate headquarters in Edmonton, Canada, and, once completed, will enable the production of recombinant proteins at kilogram ...

Rituximab (Rituxan), approved by the FDA in 1997, targeted CD20 protein in B-cell non-Hodgkin’s lymphoma. It marked a significant milestone in the field of antibody engineering and production as it ...

The first licensed mAb drug is muromonab-CD3 (1986), a hybridoma derived antibody that was used for immunosuppression during organ transplantation. Rituximab (Rituxan), approved by the FDA in 1997, ...